Sigma Planning Corp Laboratory Corp Of America Holdings Transaction History

Sigma Planning Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$213.86 - $277.87 $199,745 - $259,530	-934 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$259.82 - $298.18 $4,416 - $5,069	-17 Reduced 1.79%	934 $246,000
Q4 2021 Feb 02, 2022	BUY	$271.6 - $314.21 $814 - $942	3 Added 0.32%	951 $299,000
Q3 2021 Oct 28, 2021	SELL	$274.82 - $308.34 $824 - $925	-3 Reduced 0.32%	948 $267,000
Q2 2021 Aug 13, 2021	BUY	$251.87 - $278.14 $239,528 - $264,511	951 New	951 $262,000
Q2 2020 Jul 31, 2020	SELL	$113.31 - $182.44 $226,393 - $364,515	-1,998 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$104.32 - $195.28 $208,431 - $390,169	1,998 New	1,998 $253,000
Q4 2018 Jan 31, 2019	SELL	$120.82 - $174.09 $202,735 - $292,123	-1,678 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$167.67 - $188.27 $25,821 - $28,993	154 Added 10.1%	1,678 $291,000
Q2 2018 Aug 02, 2018	BUY	$160.33 - $189.41 $244,342 - $288,660	1,524 New	1,524 $274,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.